ELI LILLY (I4V-MC-JADY)

By Carlos Sariol June 19, 2019 Ongoing/In Follow Up

No Comments

Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Rheumatoid Arthritis

Previous PostIMMUPHARMA SA (IPP-201101/006)
Next PostELI LILLY (I1F-MC-RHBX)

Leave a Reply Cancel Reply

© 2022 Latin Clinical Trial Center. All Rights Reserved.
Powered By Millennial Networks